Polihexanide 0.8 mg/mL to Manage Acanthamoeba Keratitis in Clinical Practice: A Multicentre, Retrospective Study in Poland.

Prus-Ludwig A, Machalińska A, Kokot J, Kieruzel-Radoń P, van der Laan R, Wylęgała A, Wylęgała E

Open source

DOI
10.1007/s40123-026-01513-y
Published
2026 Oct 30
Container
Ophthalmology and therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40123-026-01513-y,
  title = {Polihexanide 0.8 mg/mL to Manage Acanthamoeba Keratitis in Clinical Practice: A Multicentre, Retrospective Study in Poland.},
  author = {Prus-Ludwig A and Machalińska A and Kokot J and Kieruzel-Radoń P and van der Laan R and Wylęgała A and Wylęgała E},
  year = {2026},
  journal = {Ophthalmology and therapy},
  doi = {10.1007/s40123-026-01513-y},
  url = {https://doi.org/10.1007/s40123-026-01513-y}
}

RIS

TY  - JOUR
TI  - Polihexanide 0.8 mg/mL to Manage Acanthamoeba Keratitis in Clinical Practice: A Multicentre, Retrospective Study in Poland.
AU  - Prus-Ludwig A
AU  - Machalińska A
AU  - Kokot J
AU  - Kieruzel-Radoń P
AU  - van der Laan R
AU  - Wylęgała A
AU  - Wylęgała E
PY  - 2026
JO  - Ophthalmology and therapy
DO  - 10.1007/s40123-026-01513-y
UR  - https://doi.org/10.1007/s40123-026-01513-y
ER  - 

APA

A, P., A, M., J, K., P, K., R, V. D. L., A, W., & E, W. (2026). Polihexanide 0.8 mg/mL to Manage Acanthamoeba Keratitis in Clinical Practice: A Multicentre, Retrospective Study in Poland.. Ophthalmology and therapy. https://doi.org/10.1007/s40123-026-01513-y

Source records